Alleviating psoriasis symptoms has been a difficult feat to achieve for decades, but with new advances in the skin care industry, doctors are excited that a cure may be closer than ever before. While we still haven’t reached a final remedy yet, a new advancement in the treatment of psoriasis has people super excited. Bryhali Lotion 0.01% is a new topical treatment that uses an active ingredient called halobetasol to treat the condition. And as Allure reports, Bryhali Lotion has just been approved by the Food and Drug Administration, making doctors and patients alike excited to give the new medication a try.
The treatment, which is a “super-potent corticosteroid,” is used on affected skin and is attained through a prescription. It works to calm the inflamed skin caused by plaque psoriasis—the most common form of psoriasis—which often presents itself as dry, raised, red skin lesions covered with silvery scales.
You May Also Like: An Injection to Erase Cellulite Might Be Coming Very Soon
Unlike other psoriasis medications, Bryhali Lotion is proven to be safe for a longer time period (8 weeks!) than its competitors. Most psoriasis drugs are only considered safe for a two week period because they’ve been proved to thin the skin with additional use, however, this didn’t happen to users in clinical trials that tested Bryhali Lotion for the full eight weeks.
“Bryhali Lotion will help address an unmet need for many plaque psoriasis patients,” said Lawrence J. Green, M.D., a lead investigator on the Bryhali Lotion Phase 3 studies and associate clinical professor of Dermatology at George Washington University School of Medicine, in a press release. “Topical steroids are the most frequently used treatment for psoriasis, but come with an increased risk of adverse events and a duration of use limited to two to four weeks. With Bryhali Lotion, I’m excited to offer my patients a topical steroid option that can be used for up to eight weeks without sacrificing tolerability, and with proven efficacy.”
Possible side effects of the treatment include burning, stinging, itching and dryness at the application site, so be sure to talk to your doctor if you experience any of these symptoms when using the product. Regardless of these side effects, we can’t help but be excited about Bryhali Lotion’s FDA approval. Considering psoriasis affects 7.5 million people, it’s possible this could make a big difference in a lot of lives.
